Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: Neurogastroenterol Motil. 2023 Nov 29;36(2):e14710. doi: 10.1111/nmo.14710

Table 2.

Detailed resilience data

HC IBS GLM p-values
Male Female Sex diff
p-value
Male Female Sex diff
p-value
Dx Sex Dx*Sex

N 66 104 62 170
BRS (0–30) 23.4±0.6 22.9±0.5 0.56 19.9±0.6 20.4±0.4 0.44 <0.001 0.92 0.34
CDRISC
Total (0–100) 78.0±1.6 77.7±1.3 0.92 68.7±1.7 74.0±1.0 0.007 <0.001 0.07 0.053
Persistence (0–32) 26.1±0.6 25.7±0.5 0.58 23.0±0.6 25.1±0.4 0.001 <0.001 0.07 0.01
Emotional-Cognitive (0–28) 20.8±0.5 20.3±0.4 0.42 18.9±0.5 19.4±0.3 0.47 .002 0.93 0.28
Adaptability (0–20) 16.8±0.4 16.8±0.3 0.95 14.9±0.4 15.8±0.2 0.053 <0.001 0.20 0.17
Control-Meaning (0–12) 9.2±0.3 9.6±0.2 0.25 8.0±0.3 8.9±0.2 0.004 <0.001 0.005 0.26
Meaning (0–8) 5.0±0.3 5.3±0.2 0.44 4.0±0.3 4.9±0.2 0.01 .006 0.02 0.23
Relative resilience 0.36±.11 0.44±.09 0.61 −0.48±.12 −0.24±.07 0.08 <0.001 0.12 0.40

Data are presented as mean±standard error. Range of scores on questionnaires is indicated in parentheses. HC, healthy control; IBS, irritable bowel syndrome; CDRISC, Connor-Davidson Resilience Scale; BRS, Brief Resilience Scale